Search Within

Solid Tumor Oncology Division

  1. "Hematology-Oncology Fellows"
Formats
  1. Meeting Abstract (261)
  2. Journal Article (227)
  3. Review (37)
  4. Editorial (24)
  5. Correspondence (7)
  6. Research Letter (5)
  7. Book Section (2)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (564)
  2. Hematology-Oncology Fellows (564)
  3. Graduate Medical Education (436)
  4. GME, Medicine (423)
  5. Weinberg Fellows (344)
  6. GSK Faculty (292)

More Groups

People
  1. Charles Rudin (70)
  2. Alexander Drilon (65)
  3. Michael Berger (60)
  4. Yonina Murciano-Goroff (51)
  5. Andrea Cercek Hanjis (46)
  6. Bob Li (46)

More People

Years
  1. 2025 (34)
  2. 2024 (139)
  3. 2023 (113)
  4. 2022 (109)
  5. 2021 (82)
  6. 2020 (54)

More Years

Publications
  1. Journal of Clinical Oncology (162)
  2. Clinical Cancer Research (29)
  3. Annals of Oncology (28)
  4. Journal of Thoracic Oncology (27)
  5. Cancer Research (25)
  6. Cancer Discovery (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (178)
  2. American Association for Cancer Research (76)
  3. Elsevier Inc. (66)
  4. Oxford University Press (45)
  5. Nature Publishing Group (41)
  6. Cell Press (24)

More Publishers

Results (564)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research
    Correspondence

    Choudhury, N. J.; Riely, G. J.; Sabbatini, P. J.; Hellmann, M. D.
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Circulating tumor cell chromosomal instability and neuroendocrine phenotype by immunomorphology and poor outcomes in men with mCRPC treated with abiraterone or enzalutamide
    Journal Article

    Brown, L. C.; Halabi, S.; Schonhoft, J. D.; Yang, Q.; Luo, J.; Nanus, D. M.; Giannakakou, P.; Szmulewitz, R. Z.; Danila, D. C.; Barnett, E. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma
    Review

    Wong, J. L.; Rosenberg, J. E.
    Expert Opinion on Biological Therapy (2021)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Developing precision medicine for bladder cancer
    Review

    Guercio, B. J.; Iyer, G.; Rosenberg, J. E.
    Hematology/Oncology Clinics of North America (2021)

    Fulltext@MSK | Save
  • Treatment of metastatic extramammary Paget disease with combination ipilimumab and nivolumab: A case report
    Journal Article

    Guercio, B. J.; Iyer, G.; Kidwai, W. Z.; Lacouture, M. E.; Ghafoor, S.; Rossi, A. M.; Assis, D. N.; Chen, Y. B.; Busam, K. J.; Janjigian, Y. Y.; more...
    Case Reports in Oncology (2021)

    Fulltext@MSK | Save
  • Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
    Journal Article

    Choudhury, N. J.; Schoenfeld, A. J.; Flynn, J.; Falcon, C. J.; Rizvi, H.; Rudin, C. M.; Kris, M. G.; Arcila, M. E.; Heller, G.; Yu, H. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Spectrum of mechanisms of resistance to crizotinib and lorlatinib in ROS1 fusion–positive lung cancer
    Journal Article

    Lin, J. J.; Choudhury, N. J.; Yoda, S.; Zhu, V. W.; Johnson, T. W.; Sakhtemani, R.; Dagogo-Jack, I.; Digumarthy, S. R.; Lee, C.; Do, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • KRAS(G12C) mutation is associated with increased risk of recurrence in surgically resected lung adenocarcinoma
    Journal Article

    Jones, G. D.; Caso, R.; Tan, K. S.; Mastrogiacomo, B.; Sanchez-Vega, F.; Liu, Y.; Connolly, J. G.; Murciano-Goroff, Y. R.; Bott, M. J.; Adusumilli, P. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save